Pictet Asset Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,205
Closed -$87.7K – 2183
2026
Q1
$87.7K Hold
22,205
– – ﹤0.01% 2052
2025
Q4
$150K Buy
22,205
+7,397
+50% +$51.8K ﹤0.01% 1973
2025
Q3
$103K Hold
14,808
– – ﹤0.01% 1978
2025
Q2
$90.5K Sell
14,808
-7,386
-33% -$49.1K ﹤0.01% 1954
2025
Q1
$169K Buy
22,194
+9,549
+76% +$79.8K ﹤0.01% 1832
2024
Q4
$122K Hold
12,645
– – ﹤0.01% 1950
2024
Q3
$74.7K Hold
12,645
– – ﹤0.01% 1972
2024
Q2
$87.6K Hold
12,645
– – ﹤0.01% 1901
2024
Q1
$97.4K Hold
12,645
– – ﹤0.01% 1887
2023
Q4
$111K Sell
12,645
-4,436
-26% -$32.5K ﹤0.01% 1862
2023
Q3
$125K Buy
+17,081
New +$127K ﹤0.01% 1792

Other funds holding MDXG

Pictet Asset Management's MDXG Position: Q2 2026 in Review

Pictet Asset Management sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 22,205 shares — an estimated $87.7K sold.

Pictet Asset Management first reported a position in MDXG in Q3 2023 and held it in 11 quarters. The position peaked at $169K in Q1 2025. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Pictet Asset Management reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
  • Pictet Asset Management sold 22,205 MiMedx Group shares in Q2 2026, an estimated $87.7K.
  • Pictet Asset Management first reported a position in MiMedx Group in Q3 2023 and held it in 11 quarters.
  • Pictet Asset Management's MiMedx Group position peaked at $169K in Q1 2025.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.